Hangzhou Alltest Biotech Co. Ltd. A (688606) — Tangible Net Worth Ratio
Hangzhou Alltest Biotech Co. Ltd. A (688606) has a Tangible Net Worth Ratio of 96.5% as of March 2026. This metric is calculated by deducting intangible assets (CN¥135.29 Million) from net assets (CN¥3.88 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is Hangzhou Alltest Biotech Co. Ltd. A's working capital to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hangzhou Alltest Biotech Co. Ltd. A Tangible Net Worth Ratio (2016–2025)
This chart shows how Hangzhou Alltest Biotech Co. Ltd. A's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 96.5%, reflecting net assets of CN¥3.88 Billion with intangible assets of CN¥135.29 Million CNY. See Hangzhou Alltest Biotech Co. Ltd. A liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Hangzhou Alltest Biotech Co. Ltd. A (2016–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Hangzhou Alltest Biotech Co. Ltd. A from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Hangzhou Alltest Biotech Co. Ltd. A (688606) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.5% | CN¥3.95 Billion | CN¥136.82 Million | CN¥4.24 Billion | ▼ -0.8 pp |
| 2024 | 97.3% | CN¥3.88 Billion | CN¥104.97 Million | CN¥4.19 Billion | ▲ +0.2 pp |
| 2023 | 97.1% | CN¥3.83 Billion | CN¥110.43 Million | CN¥4.12 Billion | ▼ -0.7 pp |
| 2022 | 97.8% | CN¥4.17 Billion | CN¥93.03 Million | CN¥4.70 Billion | ▼ -1.4 pp |
| 2021 | 99.1% | CN¥3.27 Billion | CN¥28.12 Million | CN¥4.01 Billion | ▲ +2.1 pp |
| 2020 | 97.0% | CN¥972.66 Million | CN¥28.79 Million | CN¥1.15 Billion | ▲ +2.5 pp |
| 2019 | 94.6% | CN¥293.20 Million | CN¥15.88 Million | CN¥332.50 Million | ▲ +2.1 pp |
| 2018 | 92.4% | CN¥215.10 Million | CN¥16.26 Million | CN¥254.56 Million | ▲ +4.4 pp |
| 2017 | 88.0% | CN¥138.61 Million | CN¥16.65 Million | CN¥190.58 Million | ▼ -12.0 pp |
| 2016 | 100.0% | CN¥27.32 Million | CN¥0.00 | CN¥59.73 Million | — |